Suppr超能文献

登革病毒科蛋白酶辅因子复合物的血清型特异性结构差异。

Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family.

机构信息

Department of Cell Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.

出版信息

J Virol. 2010 Mar;84(6):3059-67. doi: 10.1128/JVI.02044-09. Epub 2009 Dec 30.

Abstract

With an estimated 40% of the world population at risk, dengue poses a significant threat to human health, especially in tropical and subtropical regions. Preventative and curative efforts, such as vaccine development and drug discovery, face additional challenges due to the occurrence of four antigenically distinct serotypes of the causative dengue virus (DEN1 to -4). Complex immune responses resulting from repeat assaults by the different serotypes necessitate simultaneous targeting of all forms of the virus. One of the promising targets for drug development is the highly conserved two-component viral protease NS2B-NS3, which plays an essential role in viral replication by processing the viral precursor polyprotein into functional proteins. In this paper, we report the 2.1-A crystal structure of the DEN1 NS2B hydrophilic core (residues 49 to 95) in complex with the NS3 protease domain (residues 1 to 186) carrying an internal deletion in the N terminus (residues 11 to 20). While the overall folds within the protease core are similar to those of DEN2 and DEN4 proteases, the conformation of the cofactor NS2B is dramatically different from those of other flaviviral apoprotease structures. The differences are especially apparent within its C-terminal region, implicated in substrate binding. The structure reveals for the first time serotype-specific structural elements in the dengue virus family, with the reported alternate conformation resulting from a unique metal-binding site within the DEN1 sequence. We also report the identification of a 10-residue stretch within NS3pro that separates the substrate-binding function from the catalytic turnover rate of the enzyme. Implications for broad-spectrum drug discovery are discussed.

摘要

据估计,全球有 40%的人口面临登革热风险,这对人类健康构成了重大威胁,尤其是在热带和亚热带地区。由于引起登革热的登革病毒(DEN1 至 -4)有四种抗原上明显不同的血清型,预防和治疗工作,如疫苗开发和药物发现,面临着额外的挑战。不同血清型的反复攻击导致复杂的免疫反应,需要同时针对病毒的所有形式进行靶向治疗。一种有前途的药物开发靶点是高度保守的二组分病毒蛋白酶 NS2B-NS3,它通过将病毒前体多蛋白加工成功能性蛋白,在病毒复制中发挥重要作用。在本文中,我们报告了 DEN1 NS2B 亲水区(残基 49 至 95)与 NS3 蛋白酶结构域(残基 1 至 186)复合物的 2.1-A 晶体结构,该结构域在 N 端(残基 11 至 20)带有内部缺失。虽然蛋白酶核心内的整体折叠与 DEN2 和 DEN4 蛋白酶相似,但辅助因子 NS2B 的构象与其他黄病毒衣壳蛋白酶结构明显不同。差异尤其明显在其 C 末端区域,该区域与底物结合有关。该结构首次揭示了登革热病毒家族中的血清型特异性结构元件,报告的替代构象是由 DEN1 序列中独特的金属结合位点引起的。我们还报告了在 NS3pro 内发现的一个 10 残基片段,该片段将底物结合功能与酶的催化周转率分开。讨论了广谱药物发现的意义。

相似文献

1
Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family.
J Virol. 2010 Mar;84(6):3059-67. doi: 10.1128/JVI.02044-09. Epub 2009 Dec 30.
2
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Nat Struct Mol Biol. 2006 Apr;13(4):372-3. doi: 10.1038/nsmb1073. Epub 2006 Mar 12.
3
4
A comparative biochemical analysis of the NS2B(H)-NS3pro protease complex from four dengue virus serotypes.
Biochim Biophys Acta. 2008 Jul-Aug;1780(7-8):989-94. doi: 10.1016/j.bbagen.2008.03.018. Epub 2008 Apr 7.
5
Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor.
J Gen Virol. 1999 May;80 ( Pt 5):1167-1177. doi: 10.1099/0022-1317-80-5-1167.
8
NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.
J Biol Chem. 2013 May 3;288(18):12891-900. doi: 10.1074/jbc.M112.442723. Epub 2013 Mar 19.
10
The active essential CFNS3d protein complex.
FEBS J. 2006 Aug;273(16):3650-62. doi: 10.1111/j.1742-4658.2006.05369.x.

引用本文的文献

5
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: vs. approach.
Front Cell Infect Microbiol. 2023 Feb 14;13:1061937. doi: 10.3389/fcimb.2023.1061937. eCollection 2023.
6
Flavivirus proteases: The viral Achilles heel to prevent future pandemics.
Antiviral Res. 2023 Feb;210:105516. doi: 10.1016/j.antiviral.2022.105516. Epub 2022 Dec 29.
7
and characterization of erythrosin B and derivatives against Zika virus.
Acta Pharm Sin B. 2022 Apr;12(4):1662-1670. doi: 10.1016/j.apsb.2021.10.017. Epub 2021 Oct 22.
9
Let's Get Physical: Flavivirus-Host Protein-Protein Interactions in Replication and Pathogenesis.
Front Microbiol. 2022 Mar 3;13:847588. doi: 10.3389/fmicb.2022.847588. eCollection 2022.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structure-based discovery of dengue virus protease inhibitors.
Antiviral Res. 2009 Jun;82(3):110-4. doi: 10.1016/j.antiviral.2009.02.190. Epub 2009 Feb 21.
3
Attenuated D2 16681-PDK53 vaccine: defining humoral and cell-mediated immunity.
Curr Pharm Des. 2009;15(11):1203-11. doi: 10.2174/138161209787846865.
4
Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
PLoS Negl Trop Dis. 2009;3(1):e356. doi: 10.1371/journal.pntd.0000356. Epub 2009 Jan 13.
6
Molecular targets for flavivirus drug discovery.
Antiviral Res. 2009 Jan;81(1):6-15. doi: 10.1016/j.antiviral.2008.08.004. Epub 2008 Sep 15.
7
8
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
Hum Vaccin. 2009 Jan-Feb;5(1):33-40. doi: 10.4161/hv.5.1.6348. Epub 2009 Jan 27.
10
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3.
J Virol. 2008 Jun;82(11):5279-94. doi: 10.1128/JVI.02631-07. Epub 2008 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验